What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2026-05-13 compared with 2026-02-20 · 98 added, 10 removed, 1 unchanged (99% of the section changed)

should carefully consider the risk factors discussed in “Risk Factors” in our Registration Statement on Form S-1 (333-286456)

(our “Registration Statement”) declared effective on January 9, 2026, and the prospectus contained therein (the “Prospectus”),

You should carefully consider

the risk factors discussed below as well as the risk factors discussed in Part I, Item 1A.

“Risk Factors” in our Annual Report,

which could materially affect our business, financial condition or future results.

There have been no material changes in our risk factors

from those disclosed therein.

risks described in the Prospectus are not the only risks facing the Trust.

You should also consider any risks and uncertainties described

under the caption “Risk Factors” in any applicable prospectus, prospectus supplement, registration statement or other document

that we file with the SEC before or after this date.

Additional risks and uncertainties not currently known to us or that we currently

deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

Other than as described herein, there have been no

material changes in our risk factors from those disclosed in our 2025 Annual Report on Form 10-K.

The risks described below

and in our Annual Report are not the only risks facing the Trust.

You should also consider any risks and uncertainties described under

the caption “Risk Factors” in any applicable prospectus, prospectus supplement, registration statement or other document that

we file with the SEC before or after the date of this prospectus that is incorporated by reference herein.

Additional risks and uncertainties

not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition

and/or operating results.

The Trust Agreement

includes a provision restricting Shareholders’ right to bring a derivative action.

Under Section 7.4 of the Trust

Agreement, Shareholders’ ability to bring a derivative action (i.e., to initiate a lawsuit in the name of the Trust in order to

assert a claim belonging to the Trust against a fiduciary of the Trust or against a third-party when the Trust’s management has

refused to do so) is restricted.

The Trust Agreement provides that no Shareholder will have the right, power or authority to bring or

maintain a derivative action, suit or other proceeding on behalf of the Trust unless two or more Shareholders who are eligible to bring

such derivative action under the Maryland Trust Statute and who (i) are not “Affiliates” (as defined in the Trust Agreement

and below) of one another and (ii) collectively hold at least 10% of the outstanding Shares join in the bringing or maintaining of such

action, suit or other proceeding.

“Affiliate” means (i) any Person directly or indirectly owning, controlling or holding with

power to vote 10% or more of the outstanding voting securities of such Person, (ii) any Person 10% or more of whose outstanding voting

securities are directly or indirectly owned, controlled or held with power to vote by such Person, (iii) any Person, directly or indirectly,

controlling, controlled by or under common control of such Person, (iv) any employee, officer, director, member, manager or partner of

such Person, or (v) if such Person is an employee, officer, director, member, manager or partner, any Person for which such Person acts

in any such capacity;

and “Person” means any natural person and any partnership, limited liability company, statutory trust,

corporation, association, or other legal entity.

In addition to the 10% ownership

threshold described above, the Trust Agreement imposes the following further procedural conditions on any Shareholder seeking to bring

a derivative action on behalf of the Trust:

(1) prior to bringing any such action, two or more non-affiliated Shareholders collectively

holding at least 10% of the outstanding Shares must first make a pre-suit demand upon the Sponsor to bring the subject action, unless

an effort to cause the Sponsor to bring such an action is not likely to succeed (a demand shall only be deemed not likely to succeed,

and therefore excused, if the Sponsor has a personal financial interest in the transaction at issue, and the Sponsor shall not be deemed

interested in a transaction or otherwise disqualified from ruling on the merits of a Shareholder demand by virtue of the fact that the

Sponsor receives remuneration for his or her service as Sponsor of the Trust or as a trustee or director of one or more trusts that are

under common management with or otherwise affiliated with the Trust);

and (2) unless a demand is excused pursuant to clause (1) of this

paragraph, the Sponsor must be afforded a reasonable amount of time to consider such Shareholder request and to investigate the basis

of such claim and the Sponsor shall be entitled to retain counsel or other advisors in considering the merits of the request, and the

Sponsor shall require an undertaking by the Shareholders making such request to reimburse the Trust for the expense of any such advisor

in the event the Sponsor determines not to take action.

Any decision by the Sponsor to bring, maintain, or compromise (or not to bring,

maintain, or compromise) any such court action, proceeding or claim, or to submit the matter to a vote of Shareholders, shall be made

by the Sponsor in good faith and shall be binding upon the Shareholders.

In addition to claims that must be brought derivatively under

applicable law, the Trust Agreement requires that any claim affecting all Shareholders of the Trust proportionately, based on their number

of Shares of the Trust, must also be brought as a derivative claim subject to these conditions, regardless of whether such claim involves

a violation of a Shareholder’s rights under the Trust Agreement or any other alleged violation of contractual or individual rights

that might otherwise give rise to a direct claim (and regardless, in each case, of whether such claims sound in tort, fraud or otherwise,

or are based on common law, statutory, equitable, legal or other grounds).

These provisions apply to any derivative actions brought in the name

of the Trust other than derivative claims brought under the federal U.S.

securities laws and the rules and regulations thereunder.

enforceability of Section 7.4’s derivative action threshold and procedural requirements under applicable federal or state law has

not been definitively established.

The application of such a threshold in the context of a registered exchange-traded product has not

been comprehensively addressed by the courts.

Accordingly, it is possible that a court could decline to enforce the Trust’s 10%

threshold and procedural requirements.

A Shareholder wishing to bring

a derivative action on behalf of the Trust must satisfy both the 10% ownership threshold and the pre-suit demand process described above

before commencing any such action, suit or other proceeding, further limiting the ability of a Shareholder to seek redress in the name

of the Trust.

Due to these additional requirements, a Shareholder attempting to bring or maintain a derivative action in the name of the

Trust will be required to locate other Shareholders with which it is not affiliated and that have sufficient Shares to meet the 10% threshold

based on the number of Shares outstanding on the date the claim is brought and thereafter throughout the duration of the action, suit

or proceeding.

Shareholders wishing to satisfy this ownership threshold would need to identify and coordinate with other Shareholders

of the Trust.

Because the Trust’s Shares are held in book-entry form through the DTC and beneficial ownership information is not

publicly available, individual investors may face substantial difficulty in locating other Shareholders.

There is no mechanism established

by the Trust to facilitate such shareholder coordination, and the Trust is not required to assist Shareholders in identifying one another.

Accordingly, even Shareholders who believe they have a legitimate derivative claim may, as a practical matter, be unable to satisfy the

10% threshold and bring an action.

Even if successful, this may be difficult and may result in increased costs to a Shareholder attempting

to seek redress in the name of the Trust in court.

Moreover, if Shareholders

bringing a derivative action, suit or proceeding pursuant to this provision of the Trust Agreement do not hold 10% of the outstanding

Shares on the date such an action, suit or proceeding is brought, or such Shareholders are unable to maintain Share ownership meeting

the 10% threshold throughout the duration of the action, suit or proceeding, such Shareholders’ derivative action may be subject

to dismissal.

As a result, the Trust Agreement limits the likelihood that a Shareholder will be able to successfully assert a derivative

action in the name of the Trust, even if such Shareholder believes that he or she has a valid derivative action, suit or other proceeding

to bring on behalf of the Trust.

Because the Trust’s

Shares are held in book-entry form through DTC, the beneficial owners of Shares are generally not reflected on the Trust’s share

Accordingly, any shareholder or group of Shareholders seeking to establish that they collectively hold at least 10% of the outstanding

Shares must provide documentary evidence of their beneficial ownership as of the date of the derivative demand.

Acceptable evidence may

include broker statements, DTC participant confirmations, account statements from a registered broker-dealer or bank that is a DTC participant,

or such other documentation as the Trust may reasonably require.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors